DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

 Research & Data

DRG's Research and Data portfolio delivers industry-leading primary research and insights. We provide our customers with a baseline for market intelligence.

Our gold-standard epidemiology, formulary and lives data, and digital landscape strategy expertise give customers the tools required to confidently inform commercialization decisions - from early-stage assessment and market access to launch and post-launch phases.

Brand Trends Insights Decision Resources Group
Our innovative insights help uncover the 'why', 'what', and 'how' of a brand's performance. With deep therapeutic expertise, layered onto data-driven insights, we support product success throughout the entire commercialization cycle.
Grasp the optimal treatment sequence for your oncology brand with primary market research and physician insights.
DRG’s HCP studies across 29 countries and 25 specialist segments help clients prioritize digital investment, identify emerging content and service opportunities, plan multichannel distribution, and optimize their overall HCP engagement strategy.
Digital Patient Insights Decision Resources Group
Our consumer studies, across 6 countries and 50 indications, help healthcare companies understand digital behavior and needs along the patient treatment journey, meet them with the right content and support in the right places, and plan for patient-centric solutions to drive outcomes.
Digital Payer Insights Decision Resources Group
Our study of formulary decision makers who sit on P&T committees within MCOs, PBMs, and hospitals, helps clients develop data-driven multichannel approaches for influencing formulary and pre-authorization decisions.
10-year market outlooks and bottom-up forecasts for drugs on the market and in research & development
Physician insights on adoption, trial, and usage of newly launched therapies and their impact on market dynamics within the first year of launch.
Managed Market Surveyor-Rx delivers annual medical and pharmacy benefit enrollment data by managed care organization and at multiple geographic levels to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy’s proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.
Our Global Market Access portfolio provides high-quality primary research, data and insights, and analysis to create an in-depth -- yet rapid -- understanding of global markets.
Gain insight into a disease's etiology and pathophysiology; size and forecast disease-specific markets for current and emerging therapies across major markets for common and rare diseases.
Gain insight into a disease's etiology and pathophysiology; size and forecast disease-specific markets for current and emerging therapies across major markets for common and rare diseases.
Our Inpatient Drug Tracking provides a comprehensive analysis and tracking solution.
Managed Market Surveyor-Rx delivers annual medical and pharmacy benefit enrollment data by managed care organization and at multiple geographic levels to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy’s proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.
Our Market Level Insights provide competitive and business intelligence on the leading players in the biopharmaceutical space, as well as analysis on key trends and industry events to accurately assess market potential.
Pharmacy Benefit Evaluator combines comprehensive analysis of national and local health plans’ pharmacy benefits structure with spending assessment data to provide the insights needed to identify the plans and pharmacy benefit managers that offer the greatest return.
U.S. claims data in real time uncovers shifting market dynamics and the impact of events on the immune checkpoint inhibitor space.
Our proprietary Real World Data improves market performance. These data integration solutions allow accurate targeting and improved market performance by offering a single point of truth for insights, while maintaining 100% fidelity to the underlying data, that is clear and transparent to all users.
The answers you need for understanding, finding and engaging rheumatoid arthritis patients, providers and payers across the treatment journey.
The first - and only - online dashboard to...
Our Medtech Solutions provide top insights for medical device markets across the globe. These solutions assist in providing overviews and inpatient tracking.
Grasp the optimal treatment sequence for your oncology brand with primary market research and physician insights.
10-year market outlooks and bottom-up forecasts for drugs on the market and in research & development
Physician insights on adoption, trial, and usage of newly launched therapies and their impact on market dynamics within the first year of launch.
Our Market Level Insights provide competitive and business intelligence on the leading players in the biopharmaceutical space, as well as analysis on key trends and industry events to accurately assess market potential.
U.S. claims data in real time uncovers shifting market dynamics and the impact of events on the immune checkpoint inhibitor space.
Our proprietary Real World Data improves market performance. These data integration solutions allow accurate targeting and improved market performance by offering a single point of truth for insights, while maintaining 100% fidelity to the underlying data, that is clear and transparent to all users.
The answers you need for understanding, finding and engaging rheumatoid arthritis patients, providers and payers across the treatment journey.
Managed Market Surveyor-Rx delivers annual medical and pharmacy benefit enrollment data by managed care organization and at multiple geographic levels to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy’s proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.
Our Global Market Access portfolio provides high-quality primary research, data and insights, and analysis to create an in-depth -- yet rapid -- understanding of global markets.
Managed Market Surveyor-Rx delivers annual medical and pharmacy benefit enrollment data by managed care organization and at multiple geographic levels to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy’s proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.
Pharmacy Benefit Evaluator combines comprehensive analysis of national and local health plans’ pharmacy benefits structure with spending assessment data to provide the insights needed to identify the plans and pharmacy benefit managers that offer the greatest return.
Our proprietary Real World Data improves market performance. These data integration solutions allow accurate targeting and improved market performance by offering a single point of truth for insights, while maintaining 100% fidelity to the underlying data, that is clear and transparent to all users.
The first - and only - online dashboard to...
DRG’s HCP studies across 29 countries and 25 specialist segments help clients prioritize digital investment, identify emerging content and service opportunities, plan multichannel distribution, and optimize their overall HCP engagement strategy.
Digital Patient Insights Decision Resources Group
Our consumer studies, across 6 countries and 50 indications, help healthcare companies understand digital behavior and needs along the patient treatment journey, meet them with the right content and support in the right places, and plan for patient-centric solutions to drive outcomes.
Digital Payer Insights Decision Resources Group
Our study of formulary decision makers who sit on P&T committees within MCOs, PBMs, and hospitals, helps clients develop data-driven multichannel approaches for influencing formulary and pre-authorization decisions.
Brand Trends Insights Decision Resources Group
Our innovative insights help uncover the 'why', 'what', and 'how' of a brand's performance. With deep therapeutic expertise, layered onto data-driven insights, we support product success throughout the entire commercialization cycle.
Our Inpatient Drug Tracking provides a comprehensive analysis and tracking solution.
Our proprietary Real World Data improves market performance. These data integration solutions allow accurate targeting and improved market performance by offering a single point of truth for insights, while maintaining 100% fidelity to the underlying data, that is clear and transparent to all users.
Our Medtech Solutions provide top insights for medical device markets across the globe. These solutions assist in providing overviews and inpatient tracking.